This inventor holds 1 USPTO granted patent. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Barbara Tappertzhofen: Innovator in Pharmaceutical Composition
Introduction
Barbara Tappertzhofen is a distinguished inventor based in Cologne, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating autoimmune and tumoral diseases.
Latest Patents
Barbara Tappertzhofen holds 1 patent for her invention titled "Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors." This invention relates to a pharmaceutical composition that includes compounds selected from a group of general formulas and their enantiomers, diastereomers, or pharmaceutically acceptable salts. The composition is designed for use in treating autoimmune and tumoral diseases and for immunosuppression.
Career Highlights
Barbara is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where she has been involved in groundbreaking research. Her work has garnered attention for its potential impact on medical treatments and therapies.
Collaborations
Throughout her career, Barbara has collaborated with notable colleagues, including Michael Famulok and Imke Grune. These partnerships have contributed to the advancement of her research and innovations.
Conclusion
Barbara Tappertzhofen exemplifies the spirit of innovation in the pharmaceutical industry. Her work continues to pave the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile